Biochemical outcomes: TSH brought closer to physiological values and, in several studies, reduced TPOAb and TgAb titres, together with improved thyroid hormone parameters and ultrasound findings
In the retatrutide phase 2 trial, systolic BP fell 7.4 mmHg at 12 mg at 48 weeks
WHAT WE ACTUALLY FIND IN PARK RIDGE GLP-1 care is metabolic care the patterns in our own patients panels show why we screen, not just prescribe
This data is valuable because it captures effects in broader populations than clinical trials, including people with comorbidities, those taking multiple medications, and those using doses or schedules that differ from trial protocols
Additionally, excluding patients with a diagnosis of any psychiatric diseases within one year before or one month after the index date may not be sufficient to avoid bias